SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001069530-22-000052
Filing Date
2022-10-31
Accepted
2022-10-31 16:44:25
Documents
1
Period of Report
2022-10-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1592
  Complete submission text file 0001069530-22-000052.txt   3110
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6801 N. CAPITAL OF TEXAS HWY, BUILDING 1 SUITE 300 AUSTIN TX 78731
Business Address
Cook Robert Christopher (Reporting) CIK: 0001952028 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-29959 | Film No.: 221346691